当前位置:首页 > 关于我们 > 创投导师 > 周晖

周晖 | Zhou Hui


微信图片_20210419101635.jpg

周晖

平安创投总经理
上海交通大学双学士(电子信息工程及金融学)、硕士学位。
从业10余年,拥有丰富的直接投资及基金运作管理经验。曾任国开开元副总裁、中华开发副总裁,参与管理国开FOF投资的多支医疗基金。
完成润泽科技、创业慧康、菲森科技、博圣生物、科美诊断、昌郁医药、安诺优达、药明康德、泰邦生物、新世纪医疗、

鱼跃医疗等数十个医疗及科技类项目的投资,近十家已完成IPO。
周晖获评2020年第一财经股权价值投资榜年度青年投资家,入选医疗健康
投资卓悦榜40UNDER40年度医疗健康投资人。
Zhou Hui
General manager of Ping An Ventures
Bachelor's degree (Electronic Information Engineering and Finance) and master's degree of Shanghai Jiaotong University.
Working for more than 10 years, he has rich experience in direct investment and fund operation and management. He used to be the vice president of China Development KeyWin Equity Investment Fund Management Co., Ltd. and vice president of CDIB Capital Group, and participated in the management of several medical funds invested by China Development KeyWin FoF.
He has invested in dozens of medical and technological projects, including Range Technology, Chuangye Huikang, Fussen technology, Biosan Biotechnology, Chemclin diagnostics, Xgene Pharmaceutical, Inc.,Annoroad Gene Technology, WuXi AppTec, Taibang Biologic Group, New Century Healthcare, Yuwell, and nearly 10 have completed IPO.
Zhou Hui was selected as the young investor of the year in the equity value investment list of China first finance and economics in 2020, and was selected as the annual medical and health investorv of 40under40 of the Healthcare investment ExcellentList.

0.176465s